These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14508871)

  • 1. The value of life: individual preferences and social choice. A comment to Magnus Johannesson.
    Nord E; Menzel P; Richardson J
    Health Econ; 2003 Oct; 12(10):873-7. PubMed ID: 14508871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences and person trade-offs: forcing consistency or inconsistency in health-related quality of life measures?
    Mansley EC; Elbasha EH
    Health Econ; 2003 Mar; 12(3):187-98. PubMed ID: 12605464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equity weights in the allocation of health care: the rank-dependent QALY model.
    Bleichrodt H; Diecidue E; Quiggin J
    J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the social value of health changes.
    Gyrd-Hansen D
    J Health Econ; 2004 Nov; 23(6):1101-16. PubMed ID: 15556238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cost per year of life gained: trends and internal contradictions].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2467-70. PubMed ID: 17137090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critique of DALYs: a counter-reply.
    Sayers BM; Fliedner TM
    Bull World Health Organ; 1997; 75(4):383-4. PubMed ID: 9342898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NICE discrimination.
    Rawlins M; Dillon A
    J Med Ethics; 2005 Dec; 31(12):683-4; discussion 685-8. PubMed ID: 16319226
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing the influence of gestalt-type characteristics on preferences over lifetime health profiles.
    Oliver A
    Med Decis Making; 2008; 28(5):723-31. PubMed ID: 18378938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saving lives versus life-years in rural Bangladesh: an ethical preferences approach.
    Johansson-Stenman O; Mahmud M; Martinsson P
    Health Econ; 2011 Jun; 20(6):723-36. PubMed ID: 20575149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambling with gastroesophageal reflux disease: should we worry about the QALY?
    Moayyedi P; Talley NJ
    Am J Gastroenterol; 2005 Mar; 100(3):534-6. PubMed ID: 15743347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory.
    Lancsar E; Savage E
    Health Econ; 2004 Sep; 13(9):901-7. PubMed ID: 15362181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid unfair discrimination against disabled patients in healthcare resource allocation.
    Sinclair S
    J Med Ethics; 2012 Mar; 38(3):158-62. PubMed ID: 22138724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic examination of the 2006/7 update of the Israeli national list of health services].
    Shmueli A; Nissan-Englcin E
    Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy-years equivalent: wounded but not yet dead.
    Hauber AB
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):265-9. PubMed ID: 19527099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost per year of life gained: trends and internal contradictions].
    van Dam J
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):441; author reply 441-2. PubMed ID: 17343145
    [No Abstract]   [Full Text] [Related]  

  • 20. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.